loading
Precedente Chiudi:
$3.87
Aprire:
$3.96
Volume 24 ore:
70,909
Relative Volume:
0.99
Capitalizzazione di mercato:
$3.16M
Reddito:
$4.79M
Utile/perdita netta:
$-13.42M
Rapporto P/E:
-1.1045
EPS:
-4.02
Flusso di cassa netto:
$-10.30M
1 W Prestazione:
+6.65%
1M Prestazione:
-52.55%
6M Prestazione:
-69.57%
1 anno Prestazione:
-87.47%
Intervallo 1D:
Value
$3.8154
$4.50
Intervallo di 1 settimana:
Value
$3.3358
$4.50
Portata 52W:
Value
$3.3358
$39.13

Qualigen Therapeutics Inc Stock (QLGN) Company Profile

Name
Nome
Qualigen Therapeutics Inc
Name
Telefono
(760) 918-9165
Name
Indirizzo
2042 CORTE DEL NOGAL, CALIFORNIA
Name
Dipendente
4
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
QLGN's Discussions on Twitter

Confronta QLGN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
QLGN 4.45 3.16M 4.79M -13.42M -10.30M -4.02
VRTX 449.38 115.43B 10.63B -479.80M -1.35B 13.33
REGN 744.60 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 595.35 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 246.78 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 108.16 24.89B 3.30B -501.07M 1.03B 11.54

Qualigen Therapeutics Inc Borsa (QLGN) Ultime notizie

pulisher
Nov 19, 2024

Qualigen Therapeutics secures $4.5 million in funding By Investing.com - Investing.com South Africa

Nov 19, 2024
pulisher
Nov 19, 2024

Qualigen Therapeutics secures $4.5 million in funding - Investing.com India

Nov 19, 2024
pulisher
Nov 19, 2024

Qualigen Therapeutics Announces $4.5 Million Private Placement of Convertible Preferred Shares - GlobeNewswire

Nov 19, 2024
pulisher
Nov 18, 2024

Qualigen Therapeutics (NASDAQ:QLGN) versus Ionis Pharmaceuticals (NASDAQ:IONS) Head-To-Head Review - Defense World

Nov 18, 2024
pulisher
Nov 15, 2024

Qualigen Therapeutics Inc (QLGN) Quarterly 10-Q Report - Quartzy

Nov 15, 2024
pulisher
Nov 14, 2024

Qualigen Therapeutics appoints new board member - Investing.com

Nov 14, 2024
pulisher
Nov 14, 2024

Qualigen Therapeutics appoints new board member By Investing.com - Investing.com Canada

Nov 14, 2024
pulisher
Nov 13, 2024

QLGN Stock Touches 52-Week Low at $3.71 Amid Market Challenges - Investing.com Canada

Nov 13, 2024
pulisher
Nov 11, 2024

Qualigen Therapeutics announces 1-for-50 reverse stock split - Investing.com India

Nov 11, 2024
pulisher
Nov 11, 2024

Qualigen Therapeutics announces 1-for-50 reverse stock split By Investing.com - Investing.com UK

Nov 11, 2024
pulisher
Nov 07, 2024

Qualigen Therapeutics (STU:7R90) Enterprise Value : €4.58 Mil (As of Nov. 07, 2024) - GuruFocus.com

Nov 07, 2024
pulisher
Nov 07, 2024

Qualigen Therapeutics (STU:7R90) Operating Cash Flow per Sh - GuruFocus.com

Nov 07, 2024
pulisher
Nov 07, 2024

Qualigen Therapeutics (STU:7R90) Financial Strength : 4 (As of Jun. 2024) - GuruFocus.com

Nov 07, 2024
pulisher
Nov 07, 2024

Qualigen Therapeutics (STU:7R90) Shares Outstanding (EOP) : 0.19 Mil (As of Jun. 2024) - GuruFocus.com

Nov 07, 2024
pulisher
Nov 07, 2024

Qualigen Therapeutics (STU:7R90) Long-Term Debt & Capital L - GuruFocus.com

Nov 07, 2024
pulisher
Nov 07, 2024

Qualigen Therapeutics (STU:7R90) EV-to-Revenue : (As of Nov. 07, 2024) - GuruFocus.com

Nov 07, 2024
pulisher
Nov 07, 2024

Qualigen Therapeutics (STU:7R90) Cash Flow from Financing : €1.51 Mil (TTM As of Jun. 2024) - GuruFocus.com

Nov 07, 2024
pulisher
Nov 06, 2024

Qualigen Therapeutics, Inc. Announces Chief Financial Officer Changes - Marketscreener.com

Nov 06, 2024
pulisher
Nov 06, 2024

Qualigen Therapeutics, Inc. Announces Appointment of Amy Broidrick as Executive Vice President and Chief Strategy Officer - Marketscreener.com

Nov 06, 2024
pulisher
Nov 05, 2024

QLGN stock touches 52-week high at $5.05 amid market fluctuations - Investing.com

Nov 05, 2024
pulisher
Nov 03, 2024

Qualigen Therapeutics Stock to Reverse Split on Tuesday, November 5th (NASDAQ:QLGN) - Defense World

Nov 03, 2024
pulisher
Nov 01, 2024

Shares Expected to Begin Trading on Split-Adjusted Basis on November 5, 2024 - GlobeNewswire

Nov 01, 2024
pulisher
Nov 01, 2024

Qualigen Therapeutics Announces 1-for-50 Reverse Stock Split - TipRanks

Nov 01, 2024
pulisher
Oct 30, 2024

Would I Buy Qualigen Therapeutics Inc (NASDAQ: QLGN) Stock At Any Time In The Future? - Stocks Register

Oct 30, 2024
pulisher
Oct 30, 2024

Qualigen Therapeutics announces results of annual stockholder meeting By Investing.com - Investing.com Australia

Oct 30, 2024
pulisher
Oct 29, 2024

Qualigen Therapeutics announces results of annual stockholder meeting - Investing.com India

Oct 29, 2024
pulisher
Oct 26, 2024

Qualigen Therapeutics (STU:7R9) Enterprise Value : €4.47 Mil (As of Oct. 26, 2024) - GuruFocus.com

Oct 26, 2024
pulisher
Oct 25, 2024

Stocks Under Ten Cents to Watch in October 2024 CNSP, QLGN, AKTS, CBDW, RJDG - openPR

Oct 25, 2024
pulisher
Oct 25, 2024

QLGN stock touches 52-week low at $0.11 amid market challenges - Investing.com India

Oct 25, 2024
pulisher
Oct 23, 2024

Qualigen Therapeutics faces Nasdaq delisting notice By Investing.com - Investing.com Canada

Oct 23, 2024
pulisher
Oct 22, 2024

Qualigen Therapeutics faces Nasdaq delisting notice - Investing.com India

Oct 22, 2024
pulisher
Oct 19, 2024

Qualigen Therapeutics (NASDAQ:QLGN) Shares Up 4.4% – Here’s Why - Defense World

Oct 19, 2024
pulisher
Oct 09, 2024

Qualigen Therapeutics appoints new director and audit chair By Investing.com - Investing.com South Africa

Oct 09, 2024
pulisher
Oct 09, 2024

Qualigen Therapeutics appoints new director and audit chair - Investing.com India

Oct 09, 2024
pulisher
Sep 27, 2024

Qualigen Therapeutics sees major executive reshuffle By Investing.com - Investing.com Canada

Sep 27, 2024
pulisher
Sep 27, 2024

Qualigen Therapeutics, Inc. Announces management changes. - The Manila Times

Sep 27, 2024
pulisher
Sep 26, 2024

Qualigen Therapeutics appoints new leadership amid strategic shift By Investing.com - Investing.com South Africa

Sep 26, 2024
pulisher
Sep 26, 2024

Qualigen Therapeutics, Inc. (NASDAQ:QLGN) Sees Large Decline in Short Interest - Defense World

Sep 26, 2024
pulisher
Sep 26, 2024

Qualigen Therapeutics sees major executive reshuffle - Investing.com

Sep 26, 2024
pulisher
Sep 26, 2024

Qualigen Therapeutics appoints new leadership amid strategic shift - Investing.com

Sep 26, 2024
pulisher
Sep 26, 2024

Qualigen Therapeutics Announces Executive Shakeup and Board Revamp - TipRanks

Sep 26, 2024
pulisher
Sep 23, 2024

Stock Surge: Qualigen Therapeutics Inc (QLGN) Closes at 0.17, Marking a -4.84 Increase/Decrease - The Dwinnex

Sep 23, 2024
pulisher
Sep 20, 2024

Qualigen Therapeutics granted Nasdaq listing extension - Investing.com

Sep 20, 2024
pulisher
Sep 20, 2024

Qualigen Therapeutics granted Nasdaq listing extension By Investing.com - Investing.com Australia

Sep 20, 2024
pulisher
Sep 20, 2024

Qualigen Therapeutics receives extension from Nasdaq hearings panel - TipRanks

Sep 20, 2024
pulisher
Sep 20, 2024

Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings Panel - GlobeNewswire

Sep 20, 2024

Qualigen Therapeutics Inc Azioni (QLGN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Capitalizzazione:     |  Volume (24 ore):